Tarapeutics Science Inc.
Clinical trials sponsored by Tarapeutics Science Inc., explained in plain language.
-
Can a pill target cancers with a specific gene flaw?
Disease control Not yet recruitingThis phase II trial tests an experimental drug called TR115 in people with advanced solid tumors that have a mutation in the ARID1A gene. The study includes patients with platinum-resistant ovarian clear cell carcinoma, endometrial cancer that failed immunotherapy, and other tumo…
Phase 2 • Sponsor: Tarapeutics Science Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for tough lymphoma: TR115 faces off against standard care
Disease control Not yet recruitingThis study tests a new drug called TR115 in about 180 adults with a rare blood cancer (T/NK-cell lymphoma) that has come back or not responded to prior treatments. Participants will receive either TR115 or one of several standard drugs. The main goal is to see if TR115 can slow c…
Phase 3 • Sponsor: Tarapeutics Science Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC